This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eckert, L. B. Articles by Der, C. J. Search for Related Content PubMed PubMed Citation Articles by Eckert, L. B. Articles by Der, C. J.

Involvement of Ras Activation in Human Breast Cancer Cell Signaling, Invasion, and Anoikis

¹ Lineberger Comprehensive Cancer Center, ² Department of Pharmacology, and ³ Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Although mutated forms of ras are not associated with the majority of breast cancers (<5%), there is considerable experimental evidence that hyperactive Ras can promote breast cancer growth and development. Therefore, we determined whether Ras and Ras-responsive signaling pathways were activated persistently in nine widely studied human breast cancer cell lines. Although only two of the lines harbor mutationally activated ras, we found that five of nine breast cancer cell lines showed elevated active Ras-GTP levels that may be due, in part, to HER2 activation. Unexpectedly, activation of two key Ras effector pathways, the extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase and phosphatidylinositol 3'-kinase/AKT signaling pathways, was not always associated with Ras activation. Ras activation also did not correlate with invasion or the expression of proteins associated with tumor cell invasion (estrogen receptor and cyclooxygenase 2). We then examined the role of Ras signaling in mediating resistance to matrix deprivation-induced apoptosis (anoikis). Surprisingly, we found that ERK and phosphatidylinositol 3'-kinase/AKT activation did not have significant roles in conferring anoikis resistance. Taken together, these observations show that Ras signaling exhibits significant cell context variations and that other effector pathways may be important for Ras-mediated oncogenesis, as well as for anoikis resistance, in breast cancer. Additionally, because ERK and AKT activation are not strictly associated with Ras activation, pharmacological inhibitors of these two signaling pathways may not be the best approach for inhibition of aberrant Ras function in breast cancer treatment.

This article has been cited by other articles:

				J. J. Yu, V. A. Robb, T. A. Morrison, E. A. Ariazi, M. Karbowniczek, A. Astrinidis, C. Wang, L. Hernandez-Cuebas, L. F. Seeholzer, E. Nicolas, et al. Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells PNAS, February 24, 2009; 106(8): 2635 - 2640. [Abstract] [Full Text] [PDF]

				O. Martinez-Iglesias, S. Garcia-Silva, S. P. Tenbaum, J. Regadera, F. Larcher, J. M. Paramio, B. Vennstrom, and A. Aranda Thyroid Hormone Receptor {beta}1 Acts as a Potent Suppressor of Tumor Invasiveness and Metastasis Cancer Res., January 15, 2009; 69(2): 501 - 509. [Abstract] [Full Text] [PDF]

				F. Farassati, W. Pan, F. Yamoutpour, S. Henke, M. Piedra, S. Frahm, S. Al-Tawil, W. I. Mangrum, L. F. Parada, S. D. Rabkin, et al. Ras Signaling Influences Permissiveness of Malignant Peripheral Nerve Sheath Tumor Cells to Oncolytic Herpes Am. J. Pathol., December 1, 2008; 173(6): 1861 - 1872. [Abstract] [Full Text] [PDF]

				C. K. Augustine, Y. Yoshimoto, M. Gupta, P. A. Zipfel, M. A. Selim, P. Febbo, A. M. Pendergast, W. P. Peters, and D. S. Tyler Targeting N-Cadherin Enhances Antitumor Activity of Cytotoxic Therapies in Melanoma Treatment Cancer Res., May 15, 2008; 68(10): 3777 - 3784. [Abstract] [Full Text] [PDF]

				A. Swarbrick, E. Roy, T. Allen, and J. M. Bishop Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response PNAS, April 8, 2008; 105(14): 5402 - 5407. [Abstract] [Full Text] [PDF]

				A. Plotnikov, Y. Li, T. H. Tran, W. Tang, J. P. Palazzo, H. Rui, and S. Y. Fuchs Oncogene-Mediated Inhibition of Glycogen Synthase Kinase 3{beta} Impairs Degradation of Prolactin Receptor Cancer Res., March 1, 2008; 68(5): 1354 - 1361. [Abstract] [Full Text] [PDF]

				J. Y. Cha, Q. T. Lambert, G. W. Reuther, and C. J. Der Involvement of Fibroblast Growth Factor Receptor 2 Isoform Switching in Mammary Oncogenesis Mol. Cancer Res., March 1, 2008; 6(3): 435 - 445. [Abstract] [Full Text] [PDF]

				N. Uehara, Y. Matsuoka, and A. Tsubura Mesothelin Promotes Anchorage-Independent Growth and Prevents Anoikis via Extracellular Signal-Regulated Kinase Signaling Pathway in Human Breast Cancer Cells Mol. Cancer Res., February 1, 2008; 6(2): 186 - 193. [Abstract] [Full Text] [PDF]

				L. Jadeski, J. M. Mataraza, H.-W. Jeong, Z. Li, and D. B. Sacks IQGAP1 Stimulates Proliferation and Enhances Tumorigenesis of Human Breast Epithelial Cells J. Biol. Chem., January 11, 2008; 283(2): 1008 - 1017. [Abstract] [Full Text] [PDF]

				W.-J. Oh, V. Rishi, S. Pelech, and C. Vinson Histological and proteomic analysis of reversible H-RasV12G expression in transgenic mouse skin Carcinogenesis, October 1, 2007; 28(10): 2244 - 2252. [Abstract] [Full Text] [PDF]

				H. Donninger, M. D. Vos, and G. J. Clark The RASSF1A tumor suppressor J. Cell Sci., September 15, 2007; 120(18): 3163 - 3172. [Abstract] [Full Text] [PDF]

				B. Goulet, L. Sansregret, L. Leduy, M. Bogyo, E. Weber, S. S. Chauhan, and A. Nepveu Increased Expression and Activity of Nuclear Cathepsin L in Cancer Cells Suggests a Novel Mechanism of Cell Transformation Mol. Cancer Res., September 1, 2007; 5(9): 899 - 907. [Abstract] [Full Text] [PDF]

				M. Sanchez, K. Sauve, N. Picard, and A. Tremblay The Hormonal Response of Estrogen Receptor beta Is Decreased by the Phosphatidylinositol 3-Kinase/Akt Pathway via a Phosphorylation-dependent Release of CREB-binding Protein J. Biol. Chem., February 16, 2007; 282(7): 4830 - 4840. [Abstract] [Full Text] [PDF]

				C. Min, K. H. Kirsch, Y. Zhao, S. Jeay, A. H. Palamakumbura, P. C. Trackman, and G. E. Sonenshein The Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Reverses the Invasive Phenotype of Her-2/neu-Driven Breast Cancer Cancer Res., February 1, 2007; 67(3): 1105 - 1112. [Abstract] [Full Text] [PDF]

				D. Datta, J. A. Flaxenburg, S. Laxmanan, C. Geehan, M. Grimm, A. M. Waaga-Gasser, D. M. Briscoe, and S. Pal Ras-induced Modulation of CXCL10 and Its Receptor Splice Variant CXCR3-B in MDA-MB-435 and MCF-7 Cells: Relevance for the Development of Human Breast Cancer Cancer Res., October 1, 2006; 66(19): 9509 - 9518. [Abstract] [Full Text] [PDF]

				X. Qi, J. Tang, M. Loesch, N. Pohl, S. Alkan, and G. Chen p38{gamma} Mitogen-Activated Protein Kinase Integrates Signaling Crosstalk between Ras and Estrogen Receptor to Increase Breast Cancer Invasion. Cancer Res., August 1, 2006; 66(15): 7540 - 7547. [Abstract] [Full Text] [PDF]

				C. E. Ducker, L. K. Griffel, R. A. Smith, S. N. Keller, Y. Zhuang, Z. Xia, J. D. Diller, and C. D. Smith Discovery and characterization of inhibitors of human palmitoyl acyltransferases. Mol. Cancer Ther., July 1, 2006; 5(7): 1647 - 1659. [Abstract] [Full Text] [PDF]

				S.-O. Yoon, S. Shin, and A. M. Mercurio Ras Stimulation of E2F Activity and a Consequent E2F Regulation of Integrin {alpha}6{beta}4 Promote the Invasion of Breast Carcinoma Cells. Cancer Res., June 15, 2006; 66(12): 6288 - 6295. [Abstract] [Full Text] [PDF]

				R. A. Lubet, K. Christov, M. You, R. Yao, V. E. Steele, D. W. End, M. M. Juliana, and C. J. Grubbs Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations. Mol. Cancer Ther., April 1, 2006; 5(4): 1073 - 1078. [Abstract] [Full Text] [PDF]

				S. Shahrzad, L. Quayle, C. Stone, C. Plumb, S. Shirasawa, J. W. Rak, and B. L. Coomber Ischemia-Induced K-ras Mutations in Human Colorectal Cancer Cells: Role of Microenvironmental Regulation of MSH2 Expression Cancer Res., September 15, 2005; 65(18): 8134 - 8141. [Abstract] [Full Text] [PDF]

				E. D. Emberley, Y. Niu, L. Curtis, S. Troup, S. K. Mandal, J. N. Myers, S. B. Gibson, L. C. Murphy, and P. H. Watson The S100A7-c-Jun Activation Domain Binding Protein 1 Pathway Enhances Prosurvival Pathways in Breast Cancer Cancer Res., July 1, 2005; 65(13): 5696 - 5702. [Abstract] [Full Text] [PDF]

				A. Agathanggelou, W. N. Cooper, and F. Latif Role of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers Cancer Res., May 1, 2005; 65(9): 3497 - 3508. [Abstract] [Full Text] [PDF]